BACKGROUND: The number of multislice CT (MSCT) scans performed in polytraumatized children has increased rapidly. There is growing concern regarding the radiation dose in MSCT and its long-term consequences, especially in children. OBJECTIVE: To determine the effective dose to polytraumatized children who undergo whole-body MSCT. MATERIALS AND METHODS: A total of 51 traumatized children aged 0-16 years underwent a polytrauma protocol CT scan between November 2004 and August 2006 at our institution. The effective dose was calculated retrospectively by a computer program (CT-Expo 1.5, Hannover, Germany). RESULTS: The mean effective dose was 20.8 mSv (range 8.6-48.9 mSv, SD +/- 7.9 mSv). There was no statistically significant difference in the effective dose between male and female patients. CONCLUSION: Whole-body MSCT is a superior diagnostic tool in polytraumatized children with 20.8 mSv per patient being a justified mean effective dose. In a potentially life-threatening situation whole-body MSCT provides the clinicians with relevant information to initiate life-saving therapy. Radiologists should use special paediatric protocols that include dose-saving mechanisms to keep the effective dose as low as possible. Further studies are needed to examine and advance dose-saving strategies in MSCT, especially in children.
BACKGROUND: The number of multislice CT (MSCT) scans performed in polytraumatized children has increased rapidly. There is growing concern regarding the radiation dose in MSCT and its long-term consequences, especially in children. OBJECTIVE: To determine the effective dose to polytraumatized children who undergo whole-body MSCT. MATERIALS AND METHODS: A total of 51 traumatized children aged 0-16 years underwent a polytrauma protocol CT scan between November 2004 and August 2006 at our institution. The effective dose was calculated retrospectively by a computer program (CT-Expo 1.5, Hannover, Germany). RESULTS: The mean effective dose was 20.8 mSv (range 8.6-48.9 mSv, SD +/- 7.9 mSv). There was no statistically significant difference in the effective dose between male and female patients. CONCLUSION: Whole-body MSCT is a superior diagnostic tool in polytraumatized children with 20.8 mSv per patient being a justified mean effective dose. In a potentially life-threatening situation whole-body MSCT provides the clinicians with relevant information to initiate life-saving therapy. Radiologists should use special paediatric protocols that include dose-saving mechanisms to keep the effective dose as low as possible. Further studies are needed to examine and advance dose-saving strategies in MSCT, especially in children.